Showing 1 - 7 results of 7 for search 'Youssouf Kabore', query time: 4.42s Refine Results
  1. 1
    A Tool for Assessment of Animal Health Laboratory Safety and Biosecurity: The Safety Module of the Food and Agriculture Organization’s Laboratory Mapping Tool

    A Tool for Assessment of Animal Health Laboratory Safety and Biosecurity: The Safety Module of the Food and Agriculture Organization’s Laboratory Mapping Tool by Beatrice Mouillé, Gwenaelle Dauphin, Lidewij Wiersma, Stuart D. Blacksell, Filip Claes, Wantanee Kalpravidh, Youssouf Kabore, Sharon Hietala

    Published 2018-03-01
    Get full text
    Article
  2. 2
    Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods.

    Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods. by Alfred B Tiono, David T Kangoye, Andrea M Rehman, Désiré G Kargougou, Youssouf Kaboré, Amidou Diarra, Esperance Ouedraogo, Issa Nébié, Alphonse Ouédraogo, Brenda Okech, Paul Milligan, Sodiomon B Sirima

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.

    Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children. by Sodiomon B Sirima, Alfred B Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C Bougouma, Amadou T Konaté, Youssouf Kaboré, Abdoulaye Traoré, Roma Chilengi, Issiaka Soulama, Adrian J F Luty, Pierre Druilhe, Simon Cousens, Issa Nébié

    Published 2009-10-01
    Get full text
    Article
  4. 4
    Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.

    Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a rando... by Amadou T Konaté, Jean Baptiste Yaro, Amidou Z Ouédraogo, Amidou Diarra, Adama Gansané, Issiaka Soulama, David T Kangoyé, Youssouf Kaboré, Espérance Ouédraogo, Alphonse Ouédraogo, Alfred B Tiono, Issa N Ouédraogo, Daniel Chandramohan, Simon Cousens, Paul J Milligan, Sodiomon B Sirima, Brian Greenwood, Diadier A Diallo

    Published 2011-02-01
    Get full text
    Article
  5. 5
    Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children.

    Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children. by Sodiomon B. Sirima, Alfred B. Tiono, Alphonse Ouédraogo, Amidou Diarra, André Lin Ouédraogo, Jean Baptiste Yaro, Espérance Ouédraogo, Adama Gansané, Edith C. Bougouma, Amadou T. Konaté, Youssouf Kaboré, Abdoulaye Traoré, Chilengi Roma, Issiaka Soulama, Adrian J. F. Luty, Pierre Druilhe, Simon Cousens, Issa Nébié

    Published 2010-01-01
    Get full text
    Article
  6. 6
    Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.

    Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. by Amadou T Konaté, Jean Baptiste Yaro, Amidou Z Ouédraogo, Amidou Diarra, Adama Gansané, Issiaka Soulama, David T Kangoyé, Youssouf Kaboré, Espérance Ouédraogo, Alphonse Ouédraogo, Alfred B Tiono, Issa N Ouédraogo, Daniel Chandramohan, Simon Cousens, Paul J Milligan, Sodiomon B Sirima, Brian M Greenwood, Diadier A Diallo

    Published 2011-01-01
    Get full text
    Article
  7. 7
    A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.

    A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite... by Alphonse Ouédraogo, Alfred B Tiono, Désiré Kargougou, Jean Baptiste Yaro, Esperance Ouédraogo, Youssouf Kaboré, David Kangoye, Edith C Bougouma, Adama Gansane, Noelie Henri, Amidou Diarra, Souleymane Sanon, Issiaka Soulama, Amadou T Konate, Nora L Watson, Valerie Brown, Jenny Hendriks, Maria Grazia Pau, Isabella Versteege, Edison Wiesken, Jerald Sadoff, Issa Nebie, Sodiomon B Sirima

    Published 2013-01-01
    Get full text
    Article

Search Tools: